×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

2seventy bio Inc. (TSVT) NASDAQ

$5.50 0.12 (2.23%)

Market Cap: $276.05M

As of 03/28/24 03:13 PM EDT. Market open.

(TSVT)

2seventy bio Inc. (TSVT)
NASDAQ

$5.50
0.12 (2.23%)

Market Cap: $276.05M

As of 03/28/24 03:13 PM EDT. Market open.

Add to Portfolio

we are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. with a deep understanding of cancer cell metabolism, genomics, and the human ... read more

we are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. with a deep understanding of cancer cell metabolism, genomics, and the human body’s immune response to tumor cells, we’re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. it is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nick Leschly
Full Time Employees
114
URL
Address
60 Binney Street, MA, Cambridge, 02142.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nick Leschly
Full Time Employees
114
Address
60 Binney Street, MA, Cambridge, 02142.
PRICE CHART FOR 2SEVENTY BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.34
Previous Close
$5.38
Days Range
$4.81 - $5.40
52 week range
$1.54 - $12.69
Volume
829,488
Avg. Volume (30 days)
1,521,211
Market Cap
$276.05M
Dividend Yield
-
P/E
(1.27)
Shares Outstanding
51,311,132
Open
$5.34
Previous Close
$5.38
Days Range
$4.81 - $5.40
52 week range
$1.54 - $12.69
Volume
829,488
Avg. Volume (30 days)
1,521,211
Market Cap
$276.05M
Dividend Yield
-
P/E
(1.27)
Shares Outstanding
51,311,132
FINANCIAL STATEMENTS FOR 2SEVENTY BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR 2SEVENTY BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Casdin Capital, LLCDirectorMar 25, 2024 Buy$5.07330,0001,673,9911,960,000Mar 25, 2024, 09:44 PM
Casdin Capital, LLCDirectorMar 22, 2024 Buy$5.12147,377754,0691,630,000Mar 25, 2024, 09:44 PM
Casdin Capital, LLCDirectorMar 21, 2024 Buy$4.90300,0001,470,9901,482,623Mar 25, 2024, 09:44 PM
Baird William D IIIChief Operating OfficerJan 05, 2024 Sale$3.751,3805,180161,335Jan 09, 2024, 04:09 PM
Gregory Philip DChief Scientific OfficerJan 05, 2024 Sale$3.757952,984230,842Jan 09, 2024, 04:09 PM
Leschly NickPresident and CEOJan 05, 2024 Sale$3.751,5545,8331,085,476Jan 09, 2024, 04:08 PM
Leschly NickPresident and CEOJan 03, 2024 Sale$3.8772,312279,7391,087,030Jan 05, 2024, 04:30 PM
Gregory Philip DChief Scientific OfficerJan 03, 2024 Sale$3.8725,61399,084231,637Jan 05, 2024, 04:30 PM
Baird William D IIIChief Operating OfficerJan 03, 2024 Sale$3.8733,651130,179162,715Jan 05, 2024, 04:29 PM
Leschly NickPresident and CEOAug 22, 2023 Sale$5.499,31251,0901,159,342Aug 24, 2023, 05:04 PM
Gregory Philip DChief Scientific OfficerAug 22, 2023 Sale$5.496,15933,791257,250Aug 24, 2023, 05:04 PM
Baird William D IIIChief Financial OfficerAug 22, 2023 Sale$5.497,03138,576196,366Aug 24, 2023, 05:04 PM
Kynam Global Healthcare Master Fund, LP10% OwnerAug 10, 2023 Buy$5.9686,414515,0275,142,111Aug 16, 2023, 07:11 PM
Kynam Global Healthcare Master Fund, LP10% OwnerAug 10, 2023 Buy$5.92515,4143,049,2875,953,825Aug 16, 2023, 07:11 PM
Kynam Capital Management, LP10% OwnerAug 10, 2023 Buy$5.9686,414515,0275,142,111Aug 14, 2023, 08:51 PM
Kynam Capital Management, LP10% OwnerAug 10, 2023 Buy$5.92515,4143,049,2875,953,825Aug 14, 2023, 08:51 PM
Leschly NickPresident and CEOAug 03, 2023 Sale$6.139,06055,4991,168,654Aug 07, 2023, 04:07 PM
Gregory Philip DChief Scientific OfficerAug 03, 2023 Sale$6.133,96624,295263,409Aug 07, 2023, 04:06 PM
Baird William D IIIChief Financial OfficerAug 03, 2023 Sale$6.136,90642,304203,397Aug 07, 2023, 04:06 PM
Baird William D IIIChief Financial OfficerFeb 13, 2023 Sale$12.866378,192210,303Feb 15, 2023, 05:56 PM
Heffron NicolaChief Operating OfficerFeb 07, 2023 Sale$14.706088289,182Feb 09, 2023, 04:32 PM
Gregory Philip DChief Scientific OfficerJan 11, 2023 Sale$10.631,07611,43699,518Jan 18, 2023, 05:18 PM
Heffron NicolaChief Operating OfficerJan 11, 2023 Sale$10.631281,36089,242Jan 18, 2023, 05:18 PM
Leschly NickPresident and CEOJan 11, 2023 Sale$10.632,02621,533534,393Jan 18, 2023, 05:18 PM
Baird William D IIIChief Financial OfficerJan 11, 2023 Sale$10.631,07711,44678,797Jan 18, 2023, 05:18 PM
Leschly NickPresident and CEOJan 12, 2023 Sale$10.466,58768,889536,419Jan 17, 2023, 04:30 PM
Heffron NicolaChief Operating OfficerJan 09, 2023 Sale$10.335846,03589,370Jan 11, 2023, 04:24 PM
Gregory Philip DChief Scientific OfficerJan 09, 2023 Sale$10.333,79439,210100,594Jan 11, 2023, 04:23 PM
Baird William D IIIChief Financial OfficerJan 09, 2023 Sale$10.333,22233,29879,874Jan 11, 2023, 04:23 PM
Leschly NickPresident and CEOJan 09, 2023 Sale$10.332,97930,787543,006Jan 11, 2023, 04:23 PM
Heffron NicolaChief Operating OfficerDec 05, 2022 Sale$15.432724,19889,954Dec 06, 2022, 04:47 PM
Heffron NicolaChief Operating OfficerNov 21, 2022 Sale$13.977,697107,52790,226Nov 23, 2022, 04:26 PM
Baird William D IIIChief Financial OfficerAug 05, 2022 Sale$16.234,15267,39783,096Aug 08, 2022, 05:08 PM
Gregory Philip DChief Scientific OfficerAug 05, 2022 Sale$16.232,40739,072104,388Aug 08, 2022, 05:08 PM
Leschly NickPresident and CEOAug 05, 2022 Sale$16.235,49989,263545,985Aug 08, 2022, 05:08 PM
Baird William D IIIChief Financial OfficerJul 15, 2022 Sale$13.814,08056,34487,248Jul 19, 2022, 04:22 PM
Gregory Philip DChief Scientific OfficerJul 15, 2022 Sale$13.812,36532,660106,795Jul 19, 2022, 04:22 PM
Leschly NickPresident and CEOJul 15, 2022 Sale$13.815,40474,629551,484Jul 19, 2022, 04:22 PM
Leschly NickPresident and CEOMar 17, 2022 Buy$12.20368,8574,500,055556,888Mar 22, 2022, 04:55 PM
Leschly NickPresident and CEOMar 17, 2022 Option Exercise$12.20368,8574,500,055556,888Mar 21, 2022, 05:07 PM
Baird William D IIIChief Financial OfficerFeb 17, 2022 Sale$14.784276,31157,578Feb 22, 2022, 04:08 PM
Heffron NicolaChief Operating OfficerFeb 07, 2022 Sale$16.011,63626,19455,423Feb 08, 2022, 04:34 PM
Heffron NicolaChief Operating OfficerFeb 04, 2022 Sale$15.414677,19857,059Feb 08, 2022, 04:34 PM
Baird William D IIIChief Financial OfficerJan 07, 2022 Sale$23.9189621,42158,005Jan 11, 2022, 05:33 PM
Gregory Philip DChief Scientific OfficerJan 07, 2022 Sale$23.911,45234,71461,660Jan 11, 2022, 05:33 PM
Leschly NickPresident and CEOJan 07, 2022 Sale$23.913,27078,179188,031Jan 11, 2022, 05:32 PM
Heffron NicolaChief Operating OfficerDec 07, 2021 Sale$31.062577,98357,526Dec 09, 2021, 04:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Casdin Capital, LLCDirector03/25/20241,673,991
Casdin Capital, LLCDirector03/22/2024754,069
Casdin Capital, LLCDirector03/21/20241,470,990
Baird William D IIIChief Operating Officer01/05/20245,180
Gregory Philip DChief Scientific Officer01/05/20242,984
Leschly NickPresident and CEO01/05/20245,833
Leschly NickPresident and CEO01/03/2024279,739
Gregory Philip DChief Scientific Officer01/03/202499,084
Baird William D IIIChief Operating Officer01/03/2024130,179
Leschly NickPresident and CEO08/22/202351,090
Gregory Philip DChief Scientific Officer08/22/202333,791
Baird William D IIIChief Financial Officer08/22/202338,576
Kynam Global Healthcare Master Fund, LP10% Owner08/10/2023515,027
Kynam Global Healthcare Master Fund, LP10% Owner08/10/20233,049,287
Kynam Capital Management, LP10% Owner08/10/2023515,027
Kynam Capital Management, LP10% Owner08/10/20233,049,287
Leschly NickPresident and CEO08/03/202355,499
Gregory Philip DChief Scientific Officer08/03/202324,295
Baird William D IIIChief Financial Officer08/03/202342,304
Baird William D IIIChief Financial Officer02/13/20238,192
Heffron NicolaChief Operating Officer02/07/2023882
Gregory Philip DChief Scientific Officer01/11/202311,436
Heffron NicolaChief Operating Officer01/11/20231,360
Leschly NickPresident and CEO01/11/202321,533
Baird William D IIIChief Financial Officer01/11/202311,446
Leschly NickPresident and CEO01/12/202368,889
Heffron NicolaChief Operating Officer01/09/20236,035
Gregory Philip DChief Scientific Officer01/09/202339,210
Baird William D IIIChief Financial Officer01/09/202333,298
Leschly NickPresident and CEO01/09/202330,787
Heffron NicolaChief Operating Officer12/05/20224,198
Heffron NicolaChief Operating Officer11/21/2022107,527
Baird William D IIIChief Financial Officer08/05/202267,397
Gregory Philip DChief Scientific Officer08/05/202239,072
Leschly NickPresident and CEO08/05/202289,263
Baird William D IIIChief Financial Officer07/15/202256,344
Gregory Philip DChief Scientific Officer07/15/202232,660
Leschly NickPresident and CEO07/15/202274,629
Leschly NickPresident and CEO03/17/20224,500,055
Leschly NickPresident and CEO03/17/20224,500,055
Baird William D IIIChief Financial Officer02/17/20226,311
Heffron NicolaChief Operating Officer02/07/202226,194
Heffron NicolaChief Operating Officer02/04/20227,198
Baird William D IIIChief Financial Officer01/07/202221,421
Gregory Philip DChief Scientific Officer01/07/202234,714
Leschly NickPresident and CEO01/07/202278,179
Heffron NicolaChief Operating Officer12/07/20217,983
Load More Insider Transactions
FUNDS WITH A POSITION IN 2SEVENTY BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,911,7240.00043%-11.42%Other
BAKER BROS. ADVISORS LP2,497,5260.12%No changeOther
GEODE CAPITAL MANAGEMENT, LLC1,088,8670.00049%4.16%Other
BALYASNY ASSET MANAGEMENT L.P.636,7870.00509%ExitedEvent Driven
AQR CAPITAL MANAGEMENT LLC323,8160.0026%8.36%Other
RENAISSANCE TECHNOLOGIES LLC98,8390.00066%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR 2SEVENTY BIO INC
STOCK BUYBACKS FOR 2SEVENTY BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.44%
1Q
12/31/2023
06/30/2023
0.86%
2Q
12/31/2023
03/31/2023
18.26%
3Q
12/31/2023
12/31/2022
32.79%
4Q
12/31/2023
09/30/2022
33.27%
5Q
12/31/2023
06/30/2022
33.94%
6Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.44%
1Q
06/30/2023
0.86%
2Q
03/31/2023
18.26%
3Q
12/31/2022
32.79%
4Q
09/30/2022
33.27%
5Q
06/30/2022
33.94%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR 2SEVENTY BIO INC
LOADING...